Segment Reporting (Tables)

12 Months Ended

Oct. 31, 2018

Segment Reporting [Abstract]

Schedule of Segment Information

Certain information concerning our segments for the years ended October 31, 2018 and 2017 is presented in the following table (in thousands):

	For the Years Ended October 31,
	2018			2017
Net Revenues:
Reportable Segments:
Regenerative medicine	$	689		$	–
Contract services		874			–
Total net revenues	$	1,563		$	–
Net loss:
Reportable Segments:
Regenerative medicine	$	(65,219	)	$	(130,480	)
Contract services		(222	)		–
Discontinued operations		–			(349	)
Total net loss	$	(65,441	)	$	(130,829	)

	As of  October 31, 2018		As of  October 31, 2017
Identifiable assets employed:
Reportable segments:
Regenerative medicine	$	82,512	$	20,152
Contract services		5,330		–
Discontinued operations		–		–
Total assets	$	87,842	$	20,152